Vincerx Pharma, Inc. (NASDAQ:VINC) Forecasted to Earn FY2024 Earnings of ($1.04) Per Share

Vincerx Pharma, Inc. (NASDAQ:VINC – Free Report) – Research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Vincerx Pharma in a research report issued on Tuesday, March 5th. Leerink Partnrs analyst J. Chang now expects that the company will post earnings per share of ($1.04) for the year, down from their […]

Leave a Reply

Your email address will not be published.

Previous post Astria Therapeutics, Inc. Expected to Post Q1 2024 Earnings of ($0.36) Per Share (NASDAQ:ATXS)
Next post Telsey Advisory Group Boosts Ross Stores (NASDAQ:ROST) Price Target to $160.00